OSTAR Healthcare Technology, a Washington based medical device company, announced the North American launch of its revolutionary 3SI (3 simultaneous interpretations) Advanced Diagnostic Blood Pressure Algorithm.
According to Doug Hemenway, President and CEO, “This North American launch of OSTAR 3SI algorithm and the following product releases to come, set the scene for a change in the overall role of blood pressure measurement globally. Furthermore they are vital steps in OSTAR’s commitment to improving patient outcomes while avoiding unnecessary costs, in lockstep with current federal imperatives of Patient Privacy & Accountable Care Act (PPACA).”
OSTAR – 3SI Interpretive Blood Pressure Monitoring Algorithm is the intelligent heart of the entire suite of OSTAR products, soon to be released. This unique algorithm interprets and evaluates the entire blood pressure measurement, providing meaningful early warning alerts of possible emerging Arrhythmias, Valvular and Coronary Arterial conditions to the clinical staff and patient. It is envisaged that this unique patented technology will change the relevance of the traditional automated blood pressure measurement, from that of an interesting trend measurement to a necessary useful predictive indicator of impending valvular and coronary heart disease or cardiac arrest. The 3SI algorithm will be available in all OSTAR products with a view to make it available for OEM arrangements if customer demand dictates. The OSTAR 3SI interpretive algorithm is a natural progression, based on customer driven demand and the ongoing commitment to solving heart disease while presenting a cohesive predictive tool to the global clinical and patient world.
“Over the long run this form of automated blood pressure algorithm could have an even greater impact than advent interpretive ECG algorithms or AED defibrillators,” as stated by Paul A Markham President of V3 Healthcare Strategies. The result is reduced cost to healthcare systems and ultimately, to the American healthcare consumer.